Chordate Medical Holding AB Logo

Chordate Medical Holding AB

CMH | ST

Overview

Corporate Details

ISIN(s):
SE0021486131 (+1 more)
LEI:
549300R0GG2J3S0BFN79
Country:
Sweden
Address:
C/O Regus, 164 40 Kista
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Chordate Medical Holding AB is a medical technology company that has developed, patented, and CE-marked Ozilia®, a drug-free treatment for chronic migraine and chronic rhinitis. The company's proprietary technology is based on neuromodulation, specifically Kinetic Oscillation Stimulation, offering a clinically proven alternative to conventional medications with minimal side effects. Chordate Medical is commercializing Ozilia® in selected markets within the European Union and the Middle East. The company's business strategy is focused on building value through its patent portfolio, clinical trial data, and commercial successes to attract potential acquirers.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Chordate Medical Holding AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Chordate Medical Holding AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Chordate Medical Holding AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-03-14 Tommy Hedberg Other Other 2,917 11,668.00 SEK
2024-03-26 Anders Weilandt Other Buy 800,000 41,440.00 SEK
2024-03-26 Anders Weilandt Other Buy 200,000 10,540.00 SEK
2023-05-26 Anders Weilandt Other Buy 2,000,000 84,000.00 SEK
2023-05-26 Jan Hermansson Other Buy 750,000 31,500.00 SEK
2023-05-26 Nils Henrik Milton Rammer Other Other 350,000 14,700.00 SEK
2023-05-26 Caroline Brandberg Other Other 225,000 9,450.00 SEK
2023-05-26 Tommy Hedberg Other Buy 225,000 9,450.00 SEK
2023-01-09 Anders Weilandt Other Buy 3 2.10 SEK
2022-02-25 Anders Weilandt Other Buy 51,292 3,949,484.00 SEK

Peer Companies

Company Country Ticker View
Pulsenmore Ltd. Logo
Home ultrasound device for patient self-scans, enabling remote diagnosis and prenatal monitoring.
Israel PULS
Qiagen N.V. Logo
Provides 'Sample to Insight' solutions for molecular analysis in research and clinical healthcare.
Netherlands QIA
QLife Holding AB Logo
Develops an at-home IVD platform for biomarker and virus testing from blood samples.
Sweden QLIFE
Q-Linea Logo
Develops automated systems for rapid antimicrobial susceptibility testing for hospitals.
Sweden QLINEA
Redsense Medical AB Logo
Develops a fiber optic blood loss alarm system for hemodialysis patient safety.
Sweden REDS
Revenio Group Oyj Logo
Develops ophthalmic devices and software for early detection of significant eye diseases.
Finland REG1V
RUA LIFE SCIENCES PLC Logo
Develops and licenses implantable polymer tech and provides contract manufacturing services.
United Kingdom RUA
S2Medical AB Logo
Develops advanced medtech for wound healing, infection control, and regenerative medicine.
Sweden S2M
Safe S.A. Logo
A medical technology company with a focus on orthopaedics.
France ALSAF
Safilo Group Logo
Designs, manufactures, and distributes sunglasses, optical frames, and sports eyewear globally.
Italy SFL